UA94434C2 - Экстракт коры дерева рода corynanthe и его применение, лекарственное средство, пищевой продукт с лекарственными или профилактическими свойствами и фармацевтический препарат, который его содержит - Google Patents

Экстракт коры дерева рода corynanthe и его применение, лекарственное средство, пищевой продукт с лекарственными или профилактическими свойствами и фармацевтический препарат, который его содержит

Info

Publication number
UA94434C2
UA94434C2 UAA200807765A UAA200807765A UA94434C2 UA 94434 C2 UA94434 C2 UA 94434C2 UA A200807765 A UAA200807765 A UA A200807765A UA A200807765 A UAA200807765 A UA A200807765A UA 94434 C2 UA94434 C2 UA 94434C2
Authority
UA
Ukraine
Prior art keywords
extracts
bark
medicaments
pharmaceutical preparations
preparations containing
Prior art date
Application number
UAA200807765A
Other languages
English (en)
Ukrainian (uk)
Inventor
Егон Кох
Херманн Хауер
Original Assignee
Др. Виллмар Швабе Гмбх & Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Др. Виллмар Швабе Гмбх & Ко. Кг filed Critical Др. Виллмар Швабе Гмбх & Ко. Кг
Publication of UA94434C2 publication Critical patent/UA94434C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Данное изобретение касается экстрактов коры деревьев рода Corynanthe, а именно Corynanthe Pachyceras, а также их использования для лечения и профилактики заболеваний нижних отделов мочеиспускательных путей, сексуальных расстройств, нарушений метаболизма липидов, заболеваний сердечно-сосудистой системы и острых и хронических болевых состояний. Данное изобретение также касается лекарственных средств, диетических пищевых продуктов и фармацевтических композиций, которые содержат указанные экстракты.
UAA200807765A 2005-11-08 2006-11-07 Экстракт коры дерева рода corynanthe и его применение, лекарственное средство, пищевой продукт с лекарственными или профилактическими свойствами и фармацевтический препарат, который его содержит UA94434C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005053241A DE102005053241A1 (de) 2005-11-08 2005-11-08 Extrakte aus der Rinde von Corynanthe-Arten und deren Verwendung sowie diese Extrakte enthaltende Arzneimittel, diätetische Lebensmittel und pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
UA94434C2 true UA94434C2 (ru) 2011-05-10

Family

ID=37982546

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200807765A UA94434C2 (ru) 2005-11-08 2006-11-07 Экстракт коры дерева рода corynanthe и его применение, лекарственное средство, пищевой продукт с лекарственными или профилактическими свойствами и фармацевтический препарат, который его содержит

Country Status (12)

Country Link
US (1) US20090142428A1 (ru)
EP (1) EP1945238A2 (ru)
JP (1) JP5435951B2 (ru)
KR (1) KR101306599B1 (ru)
CN (1) CN101291682A (ru)
AU (1) AU2006312678B2 (ru)
BR (1) BRPI0618634A2 (ru)
CA (1) CA2624703A1 (ru)
DE (1) DE102005053241A1 (ru)
RU (1) RU2399378C2 (ru)
UA (1) UA94434C2 (ru)
WO (1) WO2007054269A2 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101683337B (zh) * 2008-09-27 2011-12-07 复旦大学 柯楠因在制备治疗心肌损伤性心脏病药物中的用途
JP2011125331A (ja) * 2009-11-17 2011-06-30 Taisho Pharmaceutical Co Ltd 魚鱗粉末含有コーティング錠剤
CN102002039B (zh) * 2010-11-12 2012-05-09 天医堂(厦门)生物工程有限公司 一种从育亨宾树皮中提取育亨宾的方法
CN102030747A (zh) * 2010-11-19 2011-04-27 陕西嘉禾植物化工有限责任公司 一种育亨宾碱的制备方法
EP3646871A1 (en) * 2018-10-30 2020-05-06 SEROJAC PME Handels GmbH Treatment and prevention of premature ejaculation (pe)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2112344A1 (en) * 1970-10-27 1972-06-16 Omnium Chimique Sa Hypotensive, sedative extract of pseudocni - chona africana
BE758049A (en) * 1970-10-27 1971-04-01 Omnium Chimique Sa Hypotensive, sedative extract of pseudocni - chona africana
DE3204960A1 (de) * 1982-02-12 1983-08-25 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Corynanthein-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US6323211B1 (en) * 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
FR2765483B1 (fr) * 1997-07-04 2000-02-04 Philippe Gorny Medicament destine a traiter les dysfonctions erectiles
IT1293539B1 (it) * 1997-07-16 1999-03-01 Sigma Tau Ind Farmaceuti Composizione nutritiva per soggetti in stato di debilitazione causato da stress
ITMI20011237A1 (it) * 2001-06-12 2002-12-12 Enzo Leone Uso della yohimbina per la preparazione di farmaci ad attivita' immunobiologica

Also Published As

Publication number Publication date
AU2006312678B2 (en) 2013-03-28
KR20080071172A (ko) 2008-08-01
CN101291682A (zh) 2008-10-22
WO2007054269A3 (de) 2007-08-09
EP1945238A2 (de) 2008-07-23
DE102005053241A1 (de) 2007-05-16
CA2624703A1 (en) 2007-05-18
WO2007054269A2 (de) 2007-05-18
RU2399378C2 (ru) 2010-09-20
JP5435951B2 (ja) 2014-03-05
BRPI0618634A2 (pt) 2011-09-06
RU2008119965A (ru) 2009-12-20
US20090142428A1 (en) 2009-06-04
KR101306599B1 (ko) 2013-09-10
JP2009514916A (ja) 2009-04-09
AU2006312678A1 (en) 2007-05-18

Similar Documents

Publication Publication Date Title
EP1578421A4 (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISEASES AND BREAST CONDITIONS
WO2006108582A3 (en) Human marker genes and agents for diagnosis, treatment and prophylaxis of cardiovascular disorders and artherosclerosis
MY160153A (en) Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
WO2007070052A3 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
IL228952A0 (en) Medicinal preparations containing ferric-citrate for reducing the level of phosphate in the serum, and their use in the preparation of medicines for the treatment or relief of calcium-related disorders
WO2008039218A3 (en) Inhibitors of bruton's tyrosine kinase
WO2008076754A3 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
WO2006047516A3 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
UA88165C2 (en) Use of trisubstituted benzopyranones
WO2008076954A3 (en) Heterocycle compounds and methods of use thereof
BRPI0418681A (pt) um suplemento dietético para o tratamento e a prevenção de doenças do sistema digestivo e doenças relacionadas ao sistema digestivo e método de produção e administração deste
MX2007013301A (es) Agente profilactico/terapeutico para la anormalidades del metabolismo del azucar/lipidos.
WO2008096203A3 (en) Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders
UA94434C2 (ru) Экстракт коры дерева рода corynanthe и его применение, лекарственное средство, пищевой продукт с лекарственными или профилактическими свойствами и фармацевтический препарат, который его содержит
NO20083307L (no) Anvendelse av et ikke-forsapbart ekstrakt fra plantemasse ved behandling av hudaldring
HK1081861A1 (en) New synergistic combination comprising roflumilast and formoterol
Ullah et al. Epigenetic drug development for autoimmune and inflammatory diseases
WO2005116210A3 (de) Sirna und shrna gegen stat6 zur behandlung allergischer erkrankungen, pathologischer atemwegsveränderungen und von krebs
TW200626167A (en) Sophorae Radix extract for prevention and treatment of respiratory diseases
WO2007108004A3 (en) S-alkylisothiouronium derivatives for the treatment of inflammatory diseases
WO2007031140A3 (de) Extrakte aus epimedium-arten, verfahren zu ihrer herstellung und verwendung
TWI365070B (en) Pharmaceutical compositions for prevention or treatment of disorders of lipid metabolism
WO2009015447A3 (en) Polyacetal-carboxylic acids in the treatment of cancer and auto-immune disorders
Russo et al. Beneficial Effects of Manilkara zapota-Derived Bioactive Compounds in the Epigenetic Program of Neurodevelopment